Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Test of ovarian cancer multiplex xMAP technology panel

J. Vrzalová, M. Pražáková, Z. Novotný, O. Topolčan, M. Čásová, L. Jr Holubec

. 2009 ; 29 (2) : 573-576.

Language English Country Greece

Grant support
NS10258 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online

NLK Free Medical Journals from 2004 to 2 years ago
Open Access Digital Library from 2004-01-01

BACKGROUND: An ovarian cancer marker panel including leptin, prolactin, osteopontin, insulin-like growth factor II (IGFII), macrophage migration inhibitory factor and CA125 was tested for multiplex marker measurement. Multiplex was compared to single assayed tumour markers: CA125, TPS, thymidine kinase, monototal and HE4.

000      
01894naa 2200445 a 4500
001      
bmc11009485
003      
CZ-PrNML
005      
20200304074432.0
008      
110510s2009 gr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Windrichová, Jindra $7 xx0209887 $u Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University in Prague; Department of Nuclear Medicine, Faculty Hospital in Pilsen, Czech Republic
245    10
$a Test of ovarian cancer multiplex xMAP technology panel / $c J. Vrzalová, M. Pražáková, Z. Novotný, O. Topolčan, M. Čásová, L. Jr Holubec
314    __
$a Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. vrzalovaj@fnplzen.cz
520    9_
$a BACKGROUND: An ovarian cancer marker panel including leptin, prolactin, osteopontin, insulin-like growth factor II (IGFII), macrophage migration inhibitory factor and CA125 was tested for multiplex marker measurement. Multiplex was compared to single assayed tumour markers: CA125, TPS, thymidine kinase, monototal and HE4.
590    __
$a bohemika - dle Pubmed
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antigen CA-125 $x krev $7 D018394
650    _2
$a epididymální sekreční proteiny $x metabolismus $7 D030501
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory vaječníků $x krev $7 D010051
650    _2
$a peptidy $x krev $7 D010455
650    _2
$a čipová analýza proteinů $x metody $7 D040081
650    _2
$a thymidinkináza $x krev $7 D013937
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a mladý dospělý $7 D055815
650    _2
$a financování organizované $7 D005381
700    1_
$a Pražáková, Markéta. $7 _AN047340 $u Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University in Prague; Department of Nuclear Medicine, Faculty Hospital in Pilsen, Czech Republic
700    1_
$a Novotný, Zdeněk, $d 1951- $7 skuk0004353 $u Department of Gynaecology and Obstetrics, Faculty Hospital in Pilsen, Czech Republic
700    1_
$a Topolčan, Ondřej, $d 1943- $7 jn20000402383 $u Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University in Prague; Department of Nuclear Medicine, Faculty Hospital in Pilsen, Czech Republic
700    1_
$a Čásová, Miroslava $7 xx0146456 $u Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University in Prague
700    1_
$a Holubec, Luboš, $d 1972- $7 xx0068645 $u Laboratory of Immunoanalysis, Faculty of Medicine in Pilsen, Charles University in Prague; Department of Oncology, Faculty Hospital in Pilsen, Czech Republic
773    0_
$t Anticancer Research $w MED00000478 $g Roč. 29, č. 2 (2009), s. 573-576 $x 0250-7005
910    __
$a ABA008 $b x $y 2 $z 0
990    __
$a 20110513105631 $b ABA008
991    __
$a 20200304074846 $b ABA008
999    __
$a ok $b bmc $g 839039 $s 702872
BAS    __
$a 3
BMC    __
$a 2009 $b 29 $c 2 $d 573-576 $i 0250-7005 $m Anticancer research $n Anticancer Res $x MED00000478
GRA    __
$a NS10258 $p MZ0
LZP    __
$a 2011-2B09/jvme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...